112 related articles for article (PubMed ID: 30816497)
1. Myristoylated alanine rich protein kinase C substrate is a potential cancer prognostic factor that regulates cell migration and invasion in glioblastoma.
Xiang W; Peng T; Ming Y; Li S; Wang K; Wang H; Chen L; Zhou J
Oncol Rep; 2019 Apr; 41(4):2464-2470. PubMed ID: 30816497
[TBL] [Abstract][Full Text] [Related]
2. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway.
Xin J; Zhang XY; Sun DK; Tian LQ; Xu P
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3447-3454. PubMed ID: 31081099
[TBL] [Abstract][Full Text] [Related]
3. Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastoma.
Eustace NJ; Anderson JC; Langford CP; Trummell HQ; Hicks PH; Jarboe JS; Mobley JA; Hjelmeland AB; Hackney JR; Pedersen RT; Cosby K; Gillespie GY; Bonner JA; Willey CD
Int J Oncol; 2019 Jun; 54(6):2039-2053. PubMed ID: 30942445
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Upregulation of Myristoylated Alanine-Rich C-Kinase Substrate in Gastric Cancer.
Quan R; Ning Z; Wang Y; Yu W; Zhu H
Med Sci Monit; 2019 Jan; 25():279-287. PubMed ID: 30623893
[TBL] [Abstract][Full Text] [Related]
5. MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for glioma.
Jarboe JS; Anderson JC; Duarte CW; Mehta T; Nowsheen S; Hicks PH; Whitley AC; Rohrbach TD; McCubrey RO; Chiu S; Burleson TM; Bonner JA; Gillespie GY; Yang ES; Willey CD
Clin Cancer Res; 2012 Jun; 18(11):3030-41. PubMed ID: 22619307
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression.
Micallef J; Taccone M; Mukherjee J; Croul S; Busby J; Moran MF; Guha A
Cancer Res; 2009 Oct; 69(19):7548-56. PubMed ID: 19773446
[TBL] [Abstract][Full Text] [Related]
7. A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasis.
Chen CH; Thai P; Yoneda K; Adler KB; Yang PC; Wu R
Oncogene; 2014 Jul; 33(28):3696-706. PubMed ID: 23955080
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR‑205 is associated with glioblastoma cell migration, invasion, and the epithelial-mesenchymal transition, by targeting ZEB1 via the Akt/mTOR signaling pathway.
Chen W; Kong KK; Xu XK; Chen C; Li H; Wang FY; Peng XF; Zhang Z; Li P; Li JL; Li FC
Int J Oncol; 2018 Feb; 52(2):485-495. PubMed ID: 29345288
[TBL] [Abstract][Full Text] [Related]
9. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
[TBL] [Abstract][Full Text] [Related]
10. Suppression of LIM Kinase 1 and LIM Kinase 2 Limits Glioblastoma Invasion.
Chen J; Ananthanarayanan B; Springer KS; Wolf KJ; Sheyman SM; Tran VD; Kumar S
Cancer Res; 2020 Jan; 80(1):69-78. PubMed ID: 31641031
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Epsin 3 enhances migration and invasion of glioma cells by inducing epithelial‑mesenchymal transition.
Wang Y; Song W; Kan P; Huang C; Ma Z; Wu Q; Yao X; Zhang B
Oncol Rep; 2018 Nov; 40(5):3049-3059. PubMed ID: 30226603
[TBL] [Abstract][Full Text] [Related]
12. A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma.
Eustace NJ; Anderson JC; Warram JM; Widden HN; Pedersen RT; Alrefai H; Patel Z; Hicks PH; Placzek WJ; Gillespie GY; Hjelmeland AB; Willey CD
Oncogene; 2020 Nov; 39(46):6961-6974. PubMed ID: 33077834
[TBL] [Abstract][Full Text] [Related]
13. miR‑96 inhibits EMT by targeting AEG‑1 in glioblastoma cancer cells.
Feng S; Yao J; Zhang Z; Zhang Y; Zhang Z; Liu J; Tan W; Sun C; Chen L; Yu X
Mol Med Rep; 2018 Feb; 17(2):2964-2972. PubMed ID: 29257267
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen‑like‑protein 1 promotes the invasion and metastasis of gastric cancer and is associated with poor prognosis.
Zhang Y; Qiao HX; Zhou YT; Hong L; Chen JH
Mol Med Rep; 2018 Aug; 18(2):1465-1472. PubMed ID: 29845203
[TBL] [Abstract][Full Text] [Related]
15. CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.
Maciaczyk D; Picard D; Zhao L; Koch K; Herrera-Rios D; Li G; Marquardt V; Pauck D; Hoerbelt T; Zhang W; Ouwens DM; Remke M; Jiang T; Steiger HJ; Maciaczyk J; Kahlert UD
Br J Cancer; 2017 Jun; 117(1):102-112. PubMed ID: 28571041
[TBL] [Abstract][Full Text] [Related]
16. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma.
Luo D; Xu X; Li J; Chen C; Chen W; Wang F; Xie Y; Li F
Int J Oncol; 2018 Nov; 53(5):2067-2080. PubMed ID: 30106127
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of CLEC18B Associates With the Proliferation, Migration, and Prognosis of Glioblastoma.
Guo RM; Zhao CB; Li P; Zhang L; Zang SH; Yang B
ASN Neuro; 2018; 10():1759091418781949. PubMed ID: 29914265
[TBL] [Abstract][Full Text] [Related]
18. MARCKS protein overexpression in inflammatory breast cancer.
Manai M; Thomassin-Piana J; Gamoudi A; Finetti P; Lopez M; Eghozzi R; Ayadi S; Lamine OB; Manai M; Rahal K; Charafe-Jauffret E; Jacquemier J; Viens P; Birnbaum D; Boussen H; Chaffanet M; Bertucci F
Oncotarget; 2017 Jan; 8(4):6246-6257. PubMed ID: 28009981
[TBL] [Abstract][Full Text] [Related]
19. Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value.
Doghri R; Manai M; Finetti P; Driss M; Agavnian E; Lopez M; Elghardallou M; Charafe-Jauffret E; Manai M; Chaffanet M; Birnbaum D; Mrad K; Bertucci F
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295532
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-10b mediates TGF-β1-regulated glioblastoma proliferation, migration and epithelial-mesenchymal transition.
Ma C; Wei F; Xia H; Liu H; Dong X; Zhang Y; Luo Q; Liu Y; Li Y
Int J Oncol; 2017 May; 50(5):1739-1748. PubMed ID: 28393237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]